Spots Global Cancer Trial Database for observational
Every month we try and update this database with for observational cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biomarkers of CASH | NCT04467489 | Cerebral Cavern... Cavernous Angio... Hemorrhagic Mic... | observational | 18 Years - | University of Chicago | |
| A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure | NCT01241396 | Multiple Myelom... | Any MMY treatme... | 18 Years - 99 Years | Janssen Pharmaceutica N.V., Belgium | |
| Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer | NCT03728829 | Observational Prospective | Trastuzumab+TP | 18 Years - 70 Years | Hebei Medical University Fourth Hospital | |
| Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or Esophagus | NCT02991547 | Adenocarcinoma ... | Observational | 18 Years - 80 Years | The Guthrie Clinic | |
| A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer | NCT05574738 | Cancer | Observational | 18 Years - | Cancer Research UK, Glasgow | |
| Understanding Immunotherapy Resistance Mechanisms in Advanced Melanoma | NCT02694965 | Melanoma | observational | 18 Years - | Duke University | |
| Collection and Distribution of Biospecimens for Novel Research | NCT05080907 | Cancer Healthy Gastrointestina... Autoimmune Dise... Infectious Dise... Women's Health:... Dermatologic Di... Blood Disease | Observational | 1 Year - 99 Years | iSpecimen Inc | |
| Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma | NCT03253536 | Hepatocellular ... Quality of Life Stereotactic Bo... Observational | observational | 18 Years - | Ludwig-Maximilians - University of Munich | |
| A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea | NCT02556905 | Multiple Myelom... | REVLIMID® Dexamethasone | 18 Years - | Celgene | |
| Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma | NCT03253536 | Hepatocellular ... Quality of Life Stereotactic Bo... Observational | observational | 18 Years - | Ludwig-Maximilians - University of Munich | |
| Recommendations for the Treatment of Children With Burkitt's Lymphoma | NCT04425421 | Burkitt Lymphom... | OBSERVATIONAL | - 18 Years | French Africa Pediatric Oncology Group | |
| A Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal Carcinoma | NCT03096899 | Metastatic Colo... | Observational | 18 Years - | The Rogosin Institute | |
| Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma | NCT05407480 | Staging Therapeutic Rec... | Observational | 0 Months - 18 Years | French Africa Pediatric Oncology Group | |
| Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer | NCT06250829 | Non-small Cell ... Non-small Cell ... Non-small Cell ... | Observational | 18 Years - | Lawson Health Research Institute | |
| A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy for Advanced/Recurrent Non-Small Cell Lung Cancer in Japan | NCT05161325 | Non-Small Cell ... | 20 Years - | Bristol-Myers Squibb | ||
| Acalabrutinib Real World Italian obSErvational Study -ARISE | NCT06205498 | Chronic Lymphoc... | acalabrutinib | 18 Years - | AstraZeneca | |
| Breast Cancer and Chemo-amennorhea | NCT01867229 | Breast Cancer | observational | - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| English Mammography Screening Outcomes by Age, Frequency and Test Threshold | NCT05247463 | Breast Cancer | Increase in upp... Screening round... Screening test ... | 47 Years - 73 Years | University of Warwick | |
| A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands | NCT02546375 | Chronic Myeloid... | Bosutinib | 18 Years - | Pfizer | |
| Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia | NCT02110394 | Chronic Lymphoc... | bendamustine rituximab | 18 Years - | Astellas Pharma Inc | |
| Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | NCT03452501 | Inflammatory Bo... Crohn Disease Fistulizing Cro... Ulcerative Coli... | Infliximab | 18 Years - | Hikma Pharmaceuticals LLC | |
| An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer | NCT05592483 | Breast Cancer | None (Observati... | 18 Years - 130 Years | AstraZeneca | |
| Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | NCT05259605 | Glioma Glioneuronal Tu... Choroid Plexus ... Pineal Tumors Germ Cell Tumor Tumor of the Se... Diffuse Midline... Ependymoma Embryonal Tumor Pineal Tumor Hemangiopericyt... Hemangioblastom... Melanocytic Tum... | Observational | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Biological Sample Collection for Research and Biobanking | NCT04270604 | Parkinson Disea... Diabetes Mellit... Macular Degener... ALS Cancer Alzheimer Disea... Huntington Dise... | Biological samp... | 1 Month - 100 Years | New York Stem Cell Foundation Research Institute | |
| CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage | NCT05333874 | Breast Cancer, ... | Neoadjuvant che... Observational | 18 Years - | Rutgers, The State University of New Jersey | |
| Breast Cancer and Chemo-amennorhea | NCT01867229 | Breast Cancer | observational | - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Medication Adherence and Non-adherence in Adults With Rare Disease | NCT04541875 | Cystic Fibrosis Hemophilia A Hemophilia B Idiopathic Pulm... Myasthenia Grav... Sickle Cell Dis... | MAR-Scale | 18 Years - | Xperiome | |
| Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan | NCT05399329 | Breast Cancer | Palbociclib Endocrine thera... | 20 Years - | Pfizer | |
| Oral Chemotherapy and Quality of Care | NCT03561467 | Cancer | Observational | 18 Years - | University Hospital, Caen | |
| Study Investigating the Interactions of Bone and Hematopoiesis in the Elderly | NCT02867085 | Myelodysplastic... | Observational | 60 Years - | Technische Universität Dresden | |
| Breast Screening Atypia and Subsequent Development of Cancer in England | NCT05402436 | Breast Cancer | A diagnosis of ... | 47 Years - 73 Years | University of Warwick | |
| A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic Cancer | NCT02670746 | Pancreatic Neop... | 18 Years - | Celgene | ||
| Diet, Genes and Colorectal Cancer - With Focus on Toll-like Receptor Polymorphisms | NCT03250637 | Colorectal Canc... | Observational | 50 Years - 64 Years | University of Southern Denmark | |
| A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma in Korea | NCT04036448 | Myelodysplastic... Lymphoma, Mantl... Lymphoma, Folli... | REVLIMID® | 19 Years - | Celgene | |
| Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP) | NCT01103089 | Non-Small Cell ... | - | AstraZeneca | ||
| Recommendations for the Treatment of Children With Burkitt's Lymphoma | NCT04425421 | Burkitt Lymphom... | OBSERVATIONAL | - 18 Years | French Africa Pediatric Oncology Group | |
| Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile | NCT01454297 | Multiple Myelom... | 18 Years - | Multiple Myeloma Research Foundation | ||
| A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia | NCT03911128 | Leukemia, Acute... | Observational | 0 Years - 45 Years | Karolinska University Hospital | |
| Distribution of Biospecimens From Biorepositories/Biobanks for Research Use | NCT03884400 | Cancer Pregnancy Relat... Gastro-Intestin... Cardio-Respirat... Women's Health:... Autoimmune Dise... Nephritis Healthy Neuro-Degenerat... | Specimens obtai... | - | iSpecimen Inc | |
| A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC) | NCT06163534 | Head and Neck S... | 18 Years - | Tempus AI | ||
| A Registry of Participants With Prostate Cancer in Asia | NCT02546908 | Prostatic Neopl... | No Intervention | 21 Years - | Janssen Research & Development, LLC | |
| A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients | NCT01305239 | Breast Cancer | Aromasin | 45 Years - | Pfizer | |
| The Prostate Liquid Study (PLiS) | NCT04102904 | Prostate Cancer | Observational | 40 Years - | University College, London | |
| PICAROS - Acalabrutinib RWE on 1L CLL in Spain | NCT05999877 | Chronic Lymphoc... | 18 Years - | AstraZeneca | ||
| Breast Screening Atypia and Subsequent Development of Cancer in England | NCT05402436 | Breast Cancer | A diagnosis of ... | 47 Years - 73 Years | University of Warwick | |
| Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma | NCT01585974 | Renal Cell Carc... | No intervention | 18 Years - | Bayer | |
| Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy | NCT06204406 | Upper Tract Uro... | Observational | 18 Years - 90 Years | RenJi Hospital | |
| Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients | NCT05255445 | Sickle Cell Dis... Thalassemia Pediatric Cance... | Red Blood Cell ... | - | Westat | |
| Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer | NCT01476111 | Neoplasms, Brea... | 18 Years - | GlaxoSmithKline | ||
| Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer | NCT03161834 | Metastatic Brea... | Observational | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR | NCT02387879 | Multiple Myelom... | 18 Years - | Celgene | ||
| Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients | NCT01793077 | Prostate Cancer | Depo-Eligard® | - | Astellas Pharma Inc | |
| Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice | NCT02655159 | Breast Neoplasm... | 18 Years - | Celgene Corporation | ||
| Biological Sample Collection for Research and Biobanking | NCT04270604 | Parkinson Disea... Diabetes Mellit... Macular Degener... ALS Cancer Alzheimer Disea... Huntington Dise... | Biological samp... | 1 Month - 100 Years | New York Stem Cell Foundation Research Institute | |
| Biological Sample Collection for Research and Biobanking | NCT04270604 | Parkinson Disea... Diabetes Mellit... Macular Degener... ALS Cancer Alzheimer Disea... Huntington Dise... | Biological samp... | 1 Month - 100 Years | New York Stem Cell Foundation Research Institute | |
| An Observational Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routine Practice in Patients Receiving Lenalidomide. | NCT02528838 | Multiple Myelom... | 18 Years - | Celgene | ||
| Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP) | NCT01103089 | Non-Small Cell ... | - | AstraZeneca | ||
| Myeloproliferative Neoplasms (MPNs) Patient Registry | NCT02760238 | Primary Myelofi... Polycythemia Ve... Essential Throm... Mastocytosis Leukemia, Myelo... Leukemia, Myelo... Chronic Eosinop... Myelodysplastic... Neoplasms Leukemia, Myelo... | Observational | - | University Health Network, Toronto | |
| A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer | NCT04625023 | Breast Cancer | Observational | 18 Years - | IFOM ETS - The AIRC Institute of Molecular Oncology | |
| Study of Prevalence of Ipsilateral Shoulder Pain in Patients After Thoracic Surgeries | NCT03249766 | Lung Cancer | Observational | 18 Years - 75 Years | Tata Memorial Hospital | |
| Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study | NCT05381311 | Prostate Cancer Metastatic Horm... | 18 Years - | Astellas Pharma Inc | ||
| Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients | NCT03885830 | CML, Chronic Ph... CML (Chronic My... CML - Philadelp... Chronic Myeloid... Chronic Myeloid... | Bosutinib Dasatinib Imatinib Nilotinib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting | NCT02364531 | Prostatic Neopl... | Abiraterone Ace... | 18 Years - | Janssen Inc. | |
| Stage III NSCLC RWE in Chinese Patients | NCT04023812 | Carcinoma, Non-... | 18 Years - 130 Years | AstraZeneca | ||
| Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments | NCT02284581 | Metastatic Brea... | 18 Years - | Consorzio Oncotech | ||
| Myeloproliferative Neoplasms (MPNs) Patient Registry | NCT02760238 | Primary Myelofi... Polycythemia Ve... Essential Throm... Mastocytosis Leukemia, Myelo... Leukemia, Myelo... Chronic Eosinop... Myelodysplastic... Neoplasms Leukemia, Myelo... | Observational | - | University Health Network, Toronto | |
| Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain | NCT03435341 | Leukemia, Myelo... | 60 Years - | Celgene | ||
| Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor. | NCT04625491 | Cutaneous Melan... Anatomical Path... | Observational | - | Hospital Universitario Virgen de la Arrixaca | |
| European Prospective Investigation Into Childhood Cancer | NCT05375617 | Acute Lymphobla... Brain Tumor | Observational | 3 Years - 21 Years | Columbia University | |
| The Prostate Liquid Study (PLiS) | NCT04102904 | Prostate Cancer | Observational | 40 Years - | University College, London | |
| Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | NCT03452501 | Inflammatory Bo... Crohn Disease Fistulizing Cro... Ulcerative Coli... | Infliximab | 18 Years - | Hikma Pharmaceuticals LLC | |
| Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments | NCT02284581 | Metastatic Brea... | 18 Years - | Consorzio Oncotech | ||
| Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | NCT03452501 | Inflammatory Bo... Crohn Disease Fistulizing Cro... Ulcerative Coli... | Infliximab | 18 Years - | Hikma Pharmaceuticals LLC | |
| An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands | NCT02891551 | Myelodysplastic... Leukemia, Myelo... Leukemia, Myelo... | 18 Years - | Celgene | ||
| Oral Chemotherapy and Quality of Care | NCT03561467 | Cancer | Observational | 18 Years - | University Hospital, Caen | |
| Vitamin D, Genes and Colorectal Cancer | NCT03370432 | Colorectal Canc... | Observational | 50 Years - 64 Years | University of Southern Denmark | |
| Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy | NCT06204406 | Upper Tract Uro... | Observational | 18 Years - 90 Years | RenJi Hospital | |
| Diabetes, Glucose Control, Glucose Lowering Medications, and Cancer Risk: A 10-year Population-based Historical Cohort | NCT02072902 | Diabetes Cancer | 21 Years - 90 Years | Sheba Medical Center | ||
| A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients | NCT01305239 | Breast Cancer | Aromasin | 45 Years - | Pfizer | |
| A Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal Carcinoma | NCT03096899 | Metastatic Colo... | Observational | 18 Years - | The Rogosin Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
